IMC-C103C

· Immunocore Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMC-C103C, covering 2024-10-18 to 2024-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab [Phase 1, Phase 2]